Healthcare & Life Sciences
Mysthera Therapeutics AG
Switzerland
seed
seed
Stage
1
Investors
About
Develops therapeutics targeting chronic autoimmune diseases characterized by multicellular pathology and tertiary lymphoid structures.
Explore Mysthera Therapeutics AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.